| Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor Z Culig, A Hobisch, MV Cronauer, C Radmayr, J Trapman, A Hittmair, ... Cancer research 54 (20), 5474-5478, 1994 | 1195 | 1994 |
| Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone. Z Culig, A Hobisch, MV Cronauer, AC Cato, A Hittmair, C Radmayr, ... Molecular endocrinology 7 (12), 1541-1550, 1993 | 552 | 1993 |
| Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor A Hobisch, IE Eder, T Putz, W Horninger, G Bartsch, H Klocker, Z Culig Cancer research 58 (20), 4640-4645, 1998 | 496 | 1998 |
| Switch from antagonist to agonist of the androgen receptor blocker bicalutamide is associated with prostate tumour progression in a new model system Z Culig, J Hoffmann, M Erdel, IE Eder, A Hobisch, A Hittmair, G Bartsch, ... British journal of cancer 81 (2), 242-251, 1999 | 426 | 1999 |
| Regulation of prostatic growth and function by peptide growth factors Z Culig, A Hobisch, MV Cronauer, C Radmayr, A Hittmair, J Zhang, ... The Prostate 28 (6), 392-405, 1996 | 373 | 1996 |
| Prevention and early detection of prostate cancer J Cuzick, MA Thorat, G Andriole, OW Brawley, PH Brown, Z Culig, ... The lancet oncology 15 (11), e484-e492, 2014 | 360 | 2014 |
| Distant metastases from prostatic carcinoma express androgen receptor protein A Hobisch, Z Culig, C Radmayr, G Bartsch, H Klocker, A Hittmair Cancer research 55 (14), 3068-3072, 1995 | 358 | 1995 |
| Interleukin-6 and prostate cancer progression PC Smith, A Hobisch, DL Lin, Z Culig, ET Keller Cytokine & growth factor reviews 12 (1), 33-40, 2001 | 329 | 2001 |
| Interleukin‐6 regulation of prostate cancer cell growth Z Culig, H Steiner, G Bartsch, A Hobisch Journal of cellular biochemistry 95 (3), 497-505, 2005 | 322 | 2005 |
| Androgen receptors in prostate cancer. Z Culig, H Klocker, G Bartsch, A Hobisch Endocrine-related cancer 9 (3), 155-170, 2002 | 256 | 2002 |
| The mutational landscape of prostate cancer CE Barbieri, CH Bangma, A Bjartell, JWF Catto, Z Culig, H Grönberg, ... European urology 64 (4), 567-576, 2013 | 209 | 2013 |
| Epithelial-to-mesenchymal transition leads to docetaxel resistance in prostate cancer and is mediated by reduced expression of miR-200c and miR-205 M Puhr, J Hoefer, G Schäfer, HHH Erb, SJ Oh, H Klocker, I Heidegger, ... The American journal of pathology 181 (6), 2188-2201, 2012 | 206 | 2012 |
| Immunohistochemical localization of interleukin‐6 and its receptor in benign, premalignant and malignant prostate tissue A Hobisch, H Rogatsch, A Hittmair, D Fuchs, G Bartsch Jr, H Klocker, ... The Journal of pathology 191 (3), 239-244, 2000 | 202 | 2000 |
| Inhibition of LncaP prostate cancer cells by means of androgen receptor antisense oligonucleotides IE Eder, Z Culig, R Ramoner, M Thurnher, T Putz, C Nessler-Menardi, ... Cancer gene therapy 7 (7), 997-1007, 2000 | 200 | 2000 |
| Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein … T Putz, Z Culig, IE Eder, C Nessler-Menardi, G Bartsch, H Grunicke, ... Cancer research 59 (1), 227-233, 1999 | 195 | 1999 |
| Interleukin‐6 activates PI3K/Akt pathway and regulates cyclin A1 to promote prostate cancer cell survival B Wegiel, A Bjartell, Z Culig, JL Persson International journal of cancer 122 (7), 1521-1529, 2008 | 182 | 2008 |
| Androgen receptor status of lymph node metastases from prostate cancer A Hobisch, Z Culig, C Radmayr, G Bartsch, H Klocker, A Hittmair The Prostate 28 (2), 129-135, 1996 | 182 | 1996 |
| Inhibition of the acetyltransferases p300 and CBP reveals a targetable function for p300 in the survival and invasion pathways of prostate cancer cell lines FR Santer, PPS Höschele, SJ Oh, HHH Erb, J Bouchal, IT Cavarretta, ... Molecular cancer therapeutics 10 (9), 1644-1655, 2011 | 181 | 2011 |
| Adipose tissue–derived mesenchymal stem cells expressing prodrug-converting enzyme inhibit human prostate tumor growth IT Cavarretta, V Altanerova, M Matuskova, L Kucerova, Z Culig, C Altaner Molecular Therapy 18 (1), 223-231, 2010 | 180 | 2010 |
| Expression, structure, and function of androgen receptor in advanced prostatic carcinoma Z Culig, A Hobisch, A Hittmair, H Peterziel, ACB Cato, G Bartsch, ... The Prostate 35 (1), 63-70, 1998 | 175 | 1998 |
